hereditary disease

Centogene Q2 Revenues Continue to Benefit From COVID-19 Testing as Core Business Starts to Recover

Centogene Q1 Revenues Grow More Than Fivefold Driven by COVID-19 Testing

Natera Revenues Grow 35 Percent in Q4

Twist Bioscience, Victorian Clinical Genetic Services Develop Diagnostic Exome Assay

Devyser Diagnostics Raises $15.4M Through Private Placement

Putting Expanded Carrier Screening Into Practice Requires Considerations to Avoid Pitfalls

ESHG, ACMG Differ Starkly in Recommendations for Reporting Secondary Findings From Genomic Tests

State-Funded Rapid WGS Pilot Improves Outcomes, Saves Costs in Critically Ill California Newborns

Natera Sues Progenity, Alleging Noninvasive Prenatal Test Infringes Patents

Centogene Q1 Revenues Increase 13 Percent

Quest Diagnostics Acquires Blueprint Genetics

Centogene Q3 Revenues Decrease 13 Percent Due to Non-Recurring Payments From Pharma Partners

FindGene Noninvasive Prenatal Screening Kit Gets Approval from Chinese Regulators

Blueprint Genetics, Archimedlife to Launch Biochemical Rare Disease Testing in North America